Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (21-30 of 357) with videos related to

Pageof 36
Sort By:
The Lancet. Infectious Diseases|May 13, 2022
What a second booster dose of mRNA COVID-19 vaccines tells usPaul Loubet, Odile Launay
Vaccine|June 14, 2021
Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine labelRafael Dal-Ré, Odile Launay
Expert Review of Anti-Infective Therapy|September 8, 2010
Pandemic influenza A (H1N1) in pregnant women: impact of early diagnosis and antiviral treatmentMinerva Cervantes-Gonzalez, Odile Launay
Human Vaccines & Immunotherapeutics|May 29, 2012
Vaccination against viral hepatitis of HIV-1 infected patientsBao-Chau Phung, Odile Launay
The Lancet. Respiratory Medicine|June 12, 2020
Influenza immunisation in pregnancy is efficacious and safe, but questions remainPaul Loubet, Vassilis Tsatsaris, Odile Launay
Therapie|September 1, 2005
[Post-licensing surveillance of vaccines]Odile Launay, Karine Petitprez, Mathie Lorrot
La Revue Du Praticien|May 30, 2006
[Vaccinations]Diane van der Vliet, Odile Launay
Expert Review of Respiratory Medicine|July 19, 2019
The risk of a swine influenza pandemic: still a concern?Paul Loubet, Vincent Enouf, Odile Launay
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2019
Vaccine Development: From Preclinical Studies to Phase 1/2 Clinical TrialsCécile Artaud, Leila Kara, Odile Launay
Annals of the New York Academy of Sciences|September 18, 2009
Immunizations in adult patients with systemic sclerosisOdile Launay, Loic Guillevin, Luc Mouthon
Pageof 36

Showing results (21-30 of 357) with videos related to

Sort By:
Pageof 36
The Lancet. Infectious Diseases|May 13, 2022
What a second booster dose of mRNA COVID-19 vaccines tells usPaul Loubet, Odile Launay
Vaccine|June 14, 2021
Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine labelRafael Dal-Ré, Odile Launay
Expert Review of Anti-Infective Therapy|September 8, 2010
Pandemic influenza A (H1N1) in pregnant women: impact of early diagnosis and antiviral treatmentMinerva Cervantes-Gonzalez, Odile Launay
Human Vaccines & Immunotherapeutics|May 29, 2012
Vaccination against viral hepatitis of HIV-1 infected patientsBao-Chau Phung, Odile Launay
The Lancet. Respiratory Medicine|June 12, 2020
Influenza immunisation in pregnancy is efficacious and safe, but questions remainPaul Loubet, Vassilis Tsatsaris, Odile Launay
Therapie|September 1, 2005
[Post-licensing surveillance of vaccines]Odile Launay, Karine Petitprez, Mathie Lorrot
La Revue Du Praticien|May 30, 2006
[Vaccinations]Diane van der Vliet, Odile Launay
Expert Review of Respiratory Medicine|July 19, 2019
The risk of a swine influenza pandemic: still a concern?Paul Loubet, Vincent Enouf, Odile Launay
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2019
Vaccine Development: From Preclinical Studies to Phase 1/2 Clinical TrialsCécile Artaud, Leila Kara, Odile Launay
Annals of the New York Academy of Sciences|September 18, 2009
Immunizations in adult patients with systemic sclerosisOdile Launay, Loic Guillevin, Luc Mouthon
Pageof 36